Senti Biosciences Inc reports results for the quarter ended in June - Earnings Summary

Senti Biosciences Holdings

11/08/2023 14:35

* Senti Biosciences Inc  SNTI.OQ  reported a quarterly
adjusted
loss of 42 cents​​ per share for the quarter ended in June. The
mean expectation of three analysts for the quarter was for a
loss of 48 cents per share.
    * Revenue was $937.00 thousand​; analysts expected $500.00
thousand. 
    * Senti Biosciences Inc's reported EPS for the quarter was a
loss
of 42 cents​.
    * The mean earnings estimate of analysts had risen by
about 3.4%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Senti Biosciences Inc shares had risen by 27.4% this
quarter and
lost 43.3% so far this year.
    * The company reported a quarterly loss of $18.7 million.
    * Wall Street's median 12-month price target for Senti
Biosciences
Inc is $4.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 11 at 01:35 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.48          -0.42          Beat
 Mar. 31 2023      -0.43          -0.42          Beat
 Dec. 31 2022      -0.44          -0.42          Beat
 Sep. 30 2022      -0.46          -0.38          Beat